supported by the National Natural Science Foundation of China (30873464 and 60934004);National High-Tech Research & Development Program of China (2006AA02Z311)
There are high preclinical attrition rates in current drug discovery. The efficient assessment approach in the high throughout candidate drugs screening still needs great improvement. We propose two hypotheses. First,...